Larig

Lamotrigine, the active ingredient in Larig, is an anticonvulsant presented as an oral tablet for oral use. It treats partial seizures, generalized tonic‑clonic seizures and is used as maintenance therapy for bipolar disorder in adults. GNH USA supplies Larig as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is employed in the management of seizure disorders and mood stabilization. - Partial seizures: reduces frequency and severity of focal onset seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes across the brain. - Bipolar disorder (maintenance therapy): stabilises mood and decreases risk of relapse in patients with bipolar I disorder.

Lamotrigine may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Nausea: occasional gastrointestinal upset. - Rash: non‑specific skin irritation. - Insomnia: difficulty initiating or maintaining sleep. - Fatigue: general feeling of tiredness.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Aseptic meningitis: inflammation of the meninges without infection. - Hematologic abnormalities: such as leukopenia or thrombocytopenia.

When prescribing Lamotrigine, clinicians should consider several safety measures. - Initiate therapy at low dose: titrate gradually to minimise rash risk. - Monitor hepatic function: adjust if significant liver impairment is present. - Review concomitant medications: avoid drugs that inhibit lamotrigine metabolism. - Counsel patients on rash: advise immediate reporting of any skin changes. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture.

Lamotrigine interacts with several agents that can alter its plasma concentration.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, risk of toxicity. - Carbamazepine: reduces lamotrigine exposure, may compromise efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: lower lamotrigine concentrations, may require dose adjustment. - Phenobarbital: modestly decreases lamotrigine levels. - Phenytoin: may reduce lamotrigine exposure.